ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 3647

$1.53M Total Retail Price of All Prescriptions

Rank: 70 out of 3647

714 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 714 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 714 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,566 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 872 664 1 1
LEVOTHYROXINE SODIUM 867 683 2 5
FUROSEMIDE 820 701 3 8
OMEPRAZOLE 820 608 3 3
POTASSIUM CHLORIDE 678 485 5 24
HYDROCODONE-ACETAMINOPHEN 677 546 S3 6 12
LISINOPRIL 644 502 7 4
CITALOPRAM HBR 573 504 8 25
AMLODIPINE BESYLATE 539 484 9 2
DONEPEZIL HCL 471 439 10 30
QUETIAPINE FUMARATE 390 357 11 89
METOPROLOL TARTRATE 386 318 12 7
MIRTAZAPINE 366 350 13 63
WARFARIN SODIUM 346 314 14 15
GABAPENTIN 328 288 15 17
TRAZODONE HCL 314 288 16 64
TRAMADOL HCL 312 258 17 22
MELOXICAM 296 290 18 33
NAMENDA 296 294 18 49
ALENDRONATE SODIUM 268 192 20 23
DIGOXIN 252 227 21 51
NOVOLOG 247 205 22 123
ZOLPIDEM TARTRATE 223 194 23 14
METFORMIN HCL 217 166 24 6
METOPROLOL SUCCINATE 205 165 25 18
FAMOTIDINE 203 136 26 61
FENTANYL 199 196 S2 27 147
LEVETIRACETAM 197 129 28 122
DIVALPROEX SODIUM 184 122 29 131
ADVAIR DISKUS 184 169 29 52
PRAVASTATIN SODIUM 180 100 31 16
ATORVASTATIN CALCIUM 177 152 32 13
LANTUS 172 143 33 59
HYDROCHLOROTHIAZIDE 170 144 34 9
TAMSULOSIN HCL 168 118 35 28
PREDNISONE 166 158 36 43
EXELON 162 162 37 129
KLOR-CON M20 162 123 37 121
DIOVAN 155 138 39 40
OXYBUTYNIN CHLORIDE ER 153 142 40 169
SEROQUEL 149 144 41 185
ATENOLOL 147 126 42 10
CLONIDINE HCL 137 109 43 46
CLOPIDOGREL 129 116 44 26
PLAVIX 129 117 44 39
ABILIFY 123 117 46 205
LEVOFLOXACIN 118 98 47 87
SPIRIVA 114 109 48 93
SERTRALINE HCL 112 102 49 27
AZITHROMYCIN 112 90 49 34
ISOSORBIDE MONONITRATE ER 111 94 51 56
ALLOPURINOL 111 96 51 37
CARVEDILOL 108 84 53 20
LACTULOSE 107 62 54 128
LOSARTAN POTASSIUM 106 88 55 11
NEXIUM 103 100 56 44
METOCLOPRAMIDE HCL 102 74 57 135
RISPERIDONE 100 72 58 83
NIFEDIPINE ER 98 72 59 67
DOXAZOSIN MESYLATE 95 80 60 57
LYRICA 92 55 61 120
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 86 61 110
AGGRENOX 91 79 63 267
FINASTERIDE 90 52 64 66
RAMIPRIL 90 45 64 101
ZETIA 88 62 66 96
CIPROFLOXACIN HCL 88 81 66 53
PANTOPRAZOLE SODIUM 87 73 68 38
TERAZOSIN HCL 86 60 69 103
BACLOFEN 84 61 70 97
AMOX TR-POTASSIUM CLAVULANATE 83 73 71 118
IBUPROFEN 82 64 72 55
GALANTAMINE HBR 82 82 72 245
OXYBUTYNIN CHLORIDE 82 72 72 107
BENAZEPRIL HCL 81 75 75 71
PROMETHAZINE HCL 80 67 R 76 182
PRIMIDONE 80 21 76 288
FLUTICASONE PROPIONATE 78 75 78 32
CARBIDOPA-LEVODOPA 77 66 79 127
LATANOPROST 74 57 80 218
CYMBALTA 74 60 80 79
CALCITRIOL 72 67 82 265
RANITIDINE HCL 71 46 83 29
METHADONE HCL 71 20 S2 83 174
VENLAFAXINE HCL ER 71 71 83 181
VITAMIN D2 70 70 86 100
SPIRONOLACTONE 70 38 86 77
ESCITALOPRAM OXALATE 69 52 88 65
BUSPIRONE HCL 68 61 89 162
AMLODIPINE BESYLATE-BENAZEPRIL 68 58 89 74
HYDROMORPHONE HCL 67 0 S2 91 235
NOVOLIN 70-30 66 38 92 130
LAMOTRIGINE 66 34 92 266
GLIPIZIDE 64 44 94 41
CYCLOBENZAPRINE HCL 64 48 R 94 98
NITROGLYCERIN PATCH 63 52 96 203
FLUOXETINE HCL 62 57 97 68
IPRATROPIUM BROMIDE 61 38 98 210
SYMBICORT 61 45 98 153
SINGULAIR 61 52 98 90
AMITRIPTYLINE HCL 60 48 R 101 105
LOSARTAN-HYDROCHLOROTHIAZIDE 60 40 101 48
CALCITONIN-SALMON 60 0 101 297
TRIAMTERENE-HCTZ 59 58 104 58
MECLIZINE HCL 59 56 104 85
CELEBREX 58 58 106 111
GENTAMICIN SULFATE 57 54 107 334
NAPROXEN 56 42 108 70
PROAIR HFA 56 37 108 62
DETROL LA 53 38 110 292
ALBUTEROL SULFATE 52 31 111 157
MORPHINE SULFATE ER 52 46 S2 111 163
KLOR-CON M10 52 40 111 227
LOVASTATIN 51 51 114 21
TRAMADOL HCL-ACETAMINOPHEN 51 51 114 152
VESICARE 50 50 116 209
VERAPAMIL ER 50 50 116 99
DILTIAZEM HCL 50 49 116 253
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.